Joseph P. Uberti

4.8k citations

159 papers · 3.0k indexed · h-index 27

Impact in

Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Transplantation top 2%
- Renal Transplantation Outcomes and Treatments

Papers in

Hematology 106
- Hematopoietic Stem Cell Transplantation 92
- Acute Myeloid Leukemia Research 26
- Multiple Myeloma Research and Treatments 20
Transplantation 10

Co-authors: Voravit Ratanatharathorn Lois Ayash Partow Kebriaei Lawrence G. Lum Chatchada Karanes James L.M. Ferrara Abhinav Deol C. Reynolds
Journals: Blood (35 papers)Biology of Blood and Marrow Transplantation (33 papers)Bone Marrow Transplantation (19 papers)American Journal of Hematology (6 papers)Transplantation and Cellular Therapy (5 papers)
Partner nations: United States Canada Germany

In The Last Decade

Joseph P. Uberti

150 papers receiving 2.9k citations

Peers

Countries citing papers authored by Joseph P. Uberti

Since Specialization

Citations

This map shows the geographic impact of Joseph P. Uberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph P. Uberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph P. Uberti more than expected).

Fields of papers citing papers by Joseph P. Uberti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph P. Uberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph P. Uberti. The network helps show where Joseph P. Uberti may publish in the future.

Co-authors

The 25 scholars most cited alongside Joseph P. Uberti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joseph P. Uberti Line = papers co-authored together Joseph P. Uberti links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TSC-100 and TSC-101 Demonstrate the Potential to Reduce Relapse Rates and Increase Relapse-Free Survival in Patients with AML, ALL, or MDS Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) with Reduced Intensity Conditioning (RIC): Preliminary Results from the Phase 1 Alloha Trial (NCT05473910) Transplantation and Cellular Therapy ·Monzr M. Al Malki, Alla Keyzner, Jas. J. King, Yibin Chen, Hyung C. Suh, Tania Jain, Melhem Solh, Anson Snow, Luis Piñeiro, Saar Gill, Lohith Gowda, Joseph P. Uberti, Timothy P. White, Yun Wang, Cuong V. Nguyen, Chrystal U. Louis, Shrikanta Chattopadhyay, Michelle Matzko, Ran Reshef	2025	0
2	Allogeneic stem cell transplant outcomes between TBI-containing reduced intensity and myeloablative conditioning regimens for ALL in complete remission Leukemia & lymphoma ·Dipenkumar Modi, Xinbo Yang, Seongho Kim, محمدحسین مشایخی, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti	2023	1
3	Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors Transplantation and Cellular Therapy ·Nosha Farhadfar, Michael T. Weaver, Zeina Al‐Mansour, Jean C. Yi, Heather Jim, Alison W. Loren, Navneet S. Majhail, Wataru Katawaki, Joseph P. Uberti, John R. Wingard, Debra Lynch Kelly, Karen L. Syrjala	2022	4
4	Feasibility of Outpatient CAR T Cell Therapy: Experience of a Single Institution Blood ·Shahla H. Ali, Dipenkumar Modi, محمدحسین مشایخی, Jochen Bahnmüller, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti, Abhinav Deol	2021	5
5	Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry Transplantation and Cellular Therapy ·Rachel Cusatis, Kathryn E. Flynn, Sumithira Vasu, Joseph Pidala, Lori Muffly, Joseph P. Uberti, Roni Tamari, 奈緒子大津, Jerzy Korczak, Jun-Hyung Ahn, Min Chen, M.M Ramirez Escoto, ひさ子渡邉, Lih‐Wen Mau, J. Douglas Rizzo, Wael Saber, Mary M. Horowitz, Stephanie J. Lee, Linda J. Burns, Bronwen E. Shaw	2021	4
6	Outcomes of Fludarabine, Melphalan and Total Body Irradiation as a Reduced Intensity Conditioning Regimen in Matched Donor Allogeneic Peripheral Blood Stem Cell Transplantation Transplantation and Cellular Therapy ·Dipenkumar Modi, Э Л Федотова, Seongho Kim, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti	2021	3
7	R-BEAM versus Reduced-Intensity Conditioning Regimens in Patients Undergoing Allogeneic Stem Cell Transplantation for Relapsed Refractory Diffuse Large B Cell Lymphoma Biology of Blood and Marrow Transplantation ·Dipenkumar Modi, Seongho Kim, 宁志英, Lois Ayash, Asif Alavi, Voravit Ratanatharathorn, Abhinav Deol, Joseph P. Uberti	2019	5
8	Multistate models on pleural effusion after allogeneic hematopoietic stem cell transplantation PubMed ·Anne Donnelly, Dipenkumar Modi, Hyejeong Jang, Joseph P. Uberti, Seongho Kim	2017	4
9	Geographic access to hematopoietic cell transplantation services in the United States Bone Marrow Transplantation ·Paul L. Delamater, Joseph P. Uberti	2015	22
10	Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease Biology of Blood and Marrow Transplantation ·Divaya Bhutani, Gregory Dyson, Tassneim M Ewedah, Abhinav Deol, Voravit Ratanatharathorn, Lois Ayash, Muneer H. Abidi, Lawrence G. Lum, Zaid Al‐Kadhimi, Joseph P. Uberti	2014	38
11	CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma Biology of Blood and Marrow Transplantation ·Lawrence G. Lum, Archana Thakur, Qin Liu, Abhinav Deol, Zaid Al‐Kadhimi, Lois Ayash, Muneer H. Abidi, Jairo Martínez, P. Sharp, Andrea Carla Approbato do Espírito Santo, Dana L. Schalk, Hiroshi Yano, Alice Mitchell, Florian Schweiger, Joseph P. Uberti, Voravit Ratanatharathorn	2013	32
12	A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Normal Renal Function Biology of Blood and Marrow Transplantation ·Muneer H. Abidi, Rishi Agarwal, Nishant Tageja, Lois Ayash, Abhinav Deol, Zaid Al‐Kadhimi, Judith Abrams, Simon Cronin, Agnafi Mariantina, Lawrence G. Lum, Voravit Ratanatharathorn, Jeffrey A. Zonder, Joseph P. Uberti	2012	17
13	Targeting Cytomegalovirus-Infected Cells Using T Cells Armed with Anti-CD3 × Anti-CMV Bispecific Antibody Biology of Blood and Marrow Transplantation ·Lawrence G. Lum, Mayur Ramesh, Archana Thakur, Chathura C. Ekanayake, Abhinav Deol, Joseph P. Uberti, Philip E. Pellett	2012	12
14	Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program Bone Marrow Transplantation ·Paul Shaughnessy, Joseph P. Uberti, Steven M. Devine, Ιωάννης Βούλγαρης, J. M. Vose, Ivana N. Micallef, Eric D. Jacobsen, John M. McCarty, Patrick J. Stiff, Andrew Artz, Edward D. Ball, R.B. Berryman, Michael J. Dugan, Robin Joyce, Frank J. Hsu, David G. Johns, Peter A. McSweeney	2012	29
15	Long term follow‐up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide American Journal of Hematology ·Ehab Atallah, Judith Abrams, Lois Ayash, 黄展英, Muneer H. Abidi, Voravit Ratanatharathorn, Joseph P. Uberti	2010	3
16	Induction of Immune Responses and Improved Survival after Infusions of T Cells Armed with Anti-CD3 X Anti-Her2/Neu Bispecific Antibody in Stage IV Breast Cancer Patients (Phase I). Blood ·Lawrence G. Lum, Ritesh Rathore, Don S. Dizon, Ding Wang, Zaid Al‐Kadhimi, Joseph P. Uberti, Voravit Ratanatharathorn	2007	3
17	Enhanced Anti-Breast Cancer Cytotoxicity after Autologous Peripheral Blood Stem Cell Transplant (PBSCT) by Boosting with Multiple Infusions of Activated T Cells (ATC) Armed with Anti-CD3 x Anti-Her2 Bispecific Antibody (Her2Bi) Prior to PBSCT. Blood ·Lawrence G. Lum, Zaid Al‐Kadhimi, خلدون إبراهيم الدبابي, Voravit Ratanatharathorn, Joseph P. Uberti	2007	1
18	Unrelated donor bone marrow transplantation using a chemotherapy‐only preparative regimen for adults with high‐risk acute myelogenous leukemia American Journal of Hematology ·Lois Ayash, Voravit Ratanatharathorn, Thomas Braun, Samuel Silver, Christopher M. Reynolds, Joseph P. Uberti	2006	2
19	Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes Bone Marrow Transplantation ·Joseph P. Uberti, Lois Ayash, T. Braun, C. Reynolds, S. Silver, Voravit Ratanatharathorn	2004	14
20	Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation ·Gregory A. Yanik, Beth A. Hellerstedt, Joseph R. Custer, Raymond J. Hutchinson, Deborah Kwon, James L.M. Ferrara, Joseph P. Uberti, Kenneth R. Cooke	2002	92

About Joseph P. Uberti

Joseph P. Uberti is a scholar working on Hematology, Transplantation, Oncology, Genetics and Immunology, having authored 159 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (92 papers), Acute Myeloid Leukemia Research (26 papers), CAR-T cell therapy research (22 papers), Multiple Myeloma Research and Treatments (20 papers), Acute Lymphoblastic Leukemia research (20 papers), Lymphoma Diagnosis and Treatment (19 papers), Polyomavirus and related diseases (16 papers) and Immune Cell Function and Interaction (16 papers). The work is most often cited by research in Hematology (1.5k citations), Transplantation (242 citations), Genetics (762 citations), Immunology (803 citations) and Oncology (871 citations). Joseph P. Uberti has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Voravit Ratanatharathorn, Lois Ayash, Partow Kebriaei, Lawrence G. Lum, Chatchada Karanes, James L.M. Ferrara, Abhinav Deol, C. Reynolds, V. Ratanatharathorn and Ayman O. Soubani. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, American Journal of Hematology and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact